1.
An Approach for Development of Age-, Gender-, and Ethnicity-Specific Thyrotropin Reference Limits
by Boucai, Laura
Thyroid (New York, N.Y.), 2011-01-01, Vol.21 (1), p.5-11
2.
Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer
by Xing, Mingzhao
Thyroid (New York, N.Y.), 2010-07, Vol.20 (7), p.697-706
3.
Levothyroxine Replacement Doses Are Affected by Gender and Weight, But Not Age
by Devdhar, Madhuri
Thyroid (New York, N.Y.), 2011-08-01, Vol.21 (8), p.821-827
4.
Genetic susceptibility to autoimmune thyroid disease: past, present, and future
by Tomer, Yaron
Thyroid (New York, N.Y.), 2010-07, Vol.20 (7), p.715-725
5.
A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004
by Zhu, Cairong
Thyroid (New York, N.Y.), 2009-10, Vol.19 (10), p.1061-1066
6.
Risk factors for development or deterioration of Graves' ophthalmopathy
by Stan, Marius N
Thyroid (New York, N.Y.), 2010-07, Vol.20 (7), p.777-783
7.
Metastatic phenotype is regulated by estrogen in thyroid cells
by Rajoria, Shilpi
Thyroid (New York, N.Y.), 2010-01, Vol.20 (1), p.33-41
8.
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome
by Mooney, Colin J
Thyroid (New York, N.Y.), 2009-03, Vol.19 (3), p.233-240
9.
Potent Inhibition of Thyroid Cancer Cells by the MEK Inhibitor PD0325901 and Its Potentiation by Suppression of the PI3K and NF-κB Pathways
by Liu, Dingxie
Thyroid (New York, N.Y.), 2008-08, Vol.18 (8), p.853-864
10.
Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival
by Morris, Luc G T
Thyroid (New York, N.Y.), 2010-02, Vol.20 (2), p.153-158
11.
Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension
by Rivera, Michael
Thyroid (New York, N.Y.), 2010-10, Vol.20 (10), p.1085-1093
12.
Environmental exposures and autoimmune thyroid disease
by Brent, Gregory A
Thyroid (New York, N.Y.), 2010-07, Vol.20 (7), p.755-761
13.
Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer
by Jonklaas, Jacqueline
Thyroid (New York, N.Y.), 2008-09, Vol.18 (9), p.943-952
14.
Immune mechanisms in thyroid eye disease
by Lehmann, Geniece M
Thyroid (New York, N.Y.), 2008-09, Vol.18 (9), p.959-965
15.
Cytokines, Graves' disease, and thyroid-associated ophthalmopathy
by Gianoukakis, Andrew G
Thyroid (New York, N.Y.), 2008-09, Vol.18 (9), p.953-958
16.
Clinical Evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Q x Amplified DNA Assay on the BD Viper™ System With XTR™ Technology
by Barbara Van Der Pol
Sexually transmitted diseases, 2012-02-01, Vol.39 (2), p.147-153
17.
Dual Functions of Thyroid Hormone Receptors in Vertebrate Development: The Roles of Histone-Modifying Cofactor Complexes
by Shi, Yun-Bo
Thyroid (New York, N.Y.), 2009-09-01, Vol.19 (9), p.987-999
18.
The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pha...
by Butler, Peter W
Thyroid (New York, N.Y.), 2010-12, Vol.20 (12), p.1407-1412
19.
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy
by Smith, Terry J
Thyroid (New York, N.Y.), 2008-09, Vol.18 (9), p.983-988
20.
Variation by Ethnicity in the Prevalence of Congenital Hypothyroidism Due to Thyroid Dysgenesis
by Stoppa-Vaucher, Sophie
Thyroid (New York, N.Y.), 2011-01-01, Vol.21 (1), p.13-18
